IMPEL PHARMACEUTICALS INC (IMPL) Stock Income Statement
USA - NASDAQ:IMPL - US45258K1097 - Common Stock
0.2411 USD
-0.17 (-41.79%)
0.22 USD
-0.02 (-8.75%)
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.04M | 12.65M | 670.00K | 0.00 | 0.00 | |||
| Cost Of Goods | 8.14M | 6.40M | 690.00K | N/A | N/A | |||
| Gross Profit | 10.91M | 6.26M | -20.00K | N/A | N/A | |||
| Operating Expenses | 88.35M | 89.34M | 71.46M | 45.33M | 41.57M | |||
| Research and Development | 7.10M | 11.46M | 20.56M | 27.29M | 28.81M | |||
| Selling, General, and Administrative Expenses | 81.30M | 77.89M | 50.90M | 18.05M | 12.75M | |||
| Operating Income | -77.44M | -83.08M | -71.49M | -45.33M | -41.57M | |||
| Interest Income/Expense | -11.91M | -13.84M | -2.20M | -60.00K | 420.00K | |||
| Other Income/Expense | 360.00K | -5.99M | -850.00K | -410.00K | -680.00K | |||
| Non Recurring Items | -2.58M | -3.40M | -2.00M | N/A | N/A | |||
| Income Before Taxes | -91.57M | -106.31M | -76.53M | -45.80M | -41.83M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 30.00K | |||
| Net Income | -91.57M | -106.31M | -76.67M | -46.32M | -42.36M | |||
| EBITDA | -76.62M | -81.88M | -70.40M | -44.25M | -40.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.86 | -4.53 | -5.25 | -2.39 | -2.18 | |||
| Non GAAP EPS | -4.41 | -4.54 | -3.95 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 57.30% | 49.49% | -2.99% | N/A | N/A | |||
| Profit Margin | -480.93% | -840.40% | -11443.28% | N/A | N/A | |||
| Operating Profit Margin | -406.72% | -656.76% | -10670.15% | N/A | N/A | |||
All data in USD